Bert Roland Kari Junno
Oprichter bij CYXONE AB
Oorsprong van het eerstegraads netwerk van Bert Roland Kari Junno
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
17
| Public Company | Pharmaceuticals: Major | 17 |
Aptahem AB
 Aptahem AB Pharmaceuticals: MajorHealth Technology Aptahem AB operates as a biotechnology company. The firm engages in developing drug candidates for the treatment and prevention of disease caused by blockages in blood vessels as the result of blood clots, such as deep vein thrombosis, stroke and heart failure. Its main business model is to clinically develop aptamer-based treatments for life-threatening acute conditions where coagulation and inflammation interact in the disease process. The company was founded byLuiza Jedlina, Bert Junno, Tina Persson and Johan Lindh in 2014 and is headquartered in Malmo, Sweden.
11
| Public Company | Pharmaceuticals: Major | 11 |
| Public Company | Pharmaceuticals: Major | 5 | |
Accequa AB
2
| Private Company | 2 | |
Accequa GmbH
1
| Private Company | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Bert Roland Kari Junno via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| PROBI AB | Biotechnology | Chief Executive Officer | |
| PCI BIOTECH HOLDING ASA | Biotechnology | Director/Board Member Director/Board Member | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Chief Executive Officer Chief Executive Officer | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Imperial College London | College/University | Doctorate Degree | |
| Stockholm School of Economics | College/University | Masters Business Admin | |
| University of Uppsala | College/University | Graduate Degree Doctorate Degree Corporate Officer/Principal | |
| University of Stockholm | College/University | Corporate Officer/Principal Doctorate Degree Graduate Degree | |
| University of Lund | College/University | Director/Board Member Graduate Degree Undergraduate Degree Doctorate Degree Graduate Degree Undergraduate Degree Doctorate Degree | |
| MENTICE AB | Medical Specialties | Director of Finance/CFO | |
| University of Kalmar | College/University | Masters Business Admin | |
| IMMUNOVIA AB | Pharmaceuticals: Major | Corporate Officer/Principal | |
SP Sveriges Tekniska Forskningsinstitut AB
 SP Sveriges Tekniska Forskningsinstitut AB Miscellaneous Commercial ServicesCommercial Services SP Sveriges Tekniska Forskningsinstitut AB operates as a international research institute. Its business areas include energy, information and communications technology, life science, risk, safety and security, the built environment and transportation. The company was founded in 1920 and is headquartered in Borås, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
Axcentua Pharmaceuticals AB
 Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Axcentua Pharmaceuticals AB develops anti-cancer drugs for pancreatic cancer patients. It generates investigational new drugs for diseases with unmet medical need in Sweden. The firm offers AXP107-11, multi-targeted chemosensitizer and a small-molecule anti-cancer compound for the treatment of various solid tumors, such as non-small cell lung cancers. The company was founded in 2007 by Anders Berkenstam, Stefan Rehnmark and Michael-Robin Witt and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Founder | |
| LIDDS AB | Pharmaceuticals: Major | Chairman | |
| Swedish Pharmaceutical Society | Director/Board Member | ||
| University of Linnaeus | College/University | Undergraduate Degree | |
| MENDUS AB | Biotechnology | Chairman | |
| Ideonfonden AB | Director/Board Member Chief Executive Officer | ||
| XINTELA AB | Biotechnology | Chief Tech/Sci/R&D Officer | |
| FOLLICUM AB (PUBL) | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| OBOYA HORTICULTURE INDUSTRIES AB (PUBL) | Miscellaneous Commercial Services | Director of Finance/CFO | |
| Lund University School of Economics & Management | College/University | Masters Business Admin | |
| Portendo Standoff Detection AB | Founder | ||
| INVENT MEDIC SWEDEN AB | Medical Specialties | Director of Finance/CFO | |
| Ceratmo AB | Director/Board Member | ||
| Biomedical Development Europe | Corporate Officer/Principal | ||
Edvince AB
 Edvince AB BiotechnologyHealth Technology Edvince AB engages in clinical research and development services. It operates as a biotech company that focuses on a new form of emergency treatment for stroke. The company was founded by Lars Ingvar Herbert Edvinsson in 2003 and is headquartered in Lund, Sweden. | Biotechnology | Chairman Chief Executive Officer | |
| Celus Pharmaceuticals Ltd. | Chief Executive Officer | ||
Ledningsresurs Syd AB
 Ledningsresurs Syd AB Miscellaneous Commercial ServicesCommercial Services Ledningsresurs Syd AB provides corporate consulting services. Ola Skanung has been the CEO of the Swedish company since 2010. | Miscellaneous Commercial Services | Chief Executive Officer | |
Oboya Horti Supplies AB
 Oboya Horti Supplies AB Wholesale DistributorsDistribution Services Oboya Horti Supplies AB is a Swedish company that wholesales chemical products. | Wholesale Distributors | Corporate Officer/Principal | |
| Flugsvampen Hhy AB | Chairman | ||
| Pig Sverige AB | Chairman | ||
| Classic Beauty Invest AB | Corporate Officer/Principal | ||
| Classic Beauty Göteborg AB | Corporate Officer/Principal | ||
| XO Sweden Wines & Spirits AB | Director/Board Member | ||
| FLUOGUIDE A/S | Pharmaceuticals: Major | Director of Finance/CFO | |
| ECTIN RESEARCH AB | Biotechnology | Chairman Director of Finance/CFO | |
| Galecto Biotech AB | Founder | ||
| BIOME AUSTRALIA LIMITED | Pharmaceuticals: Major | Chief Executive Officer | |
| Northern Lights Southern Cross AB | Chief Executive Officer | ||
| Aptahem Finans AB | Founder | ||
| Serstech Förvaltning AB | Founder | ||
| Mikeoo Holding AB | Founder | ||
| Holy Plantmedix AB | Founder | ||
Melius Pharma AB
 Melius Pharma AB Pharmaceuticals: MajorHealth Technology Melius Pharma AB is a Swedish clinical stage pharmaceutical company that develops new treatments for chronic cough in idiopathic pulmonary fibrosis (IPF) patients. The company is based in Lund, Sweden and is privately owned, benefiting from the support of two of Sweden's most prominent professional life science investors who bring expertise to develop the company. IPF is a chronic, progressive lung inflammation characterized by fibrosis and disruption of normal lung architecture. Melius Pharma has developed ME-015, which stabilizes ion channels in the neuronal endings in the lungs that mediate cough. ME-015 is presumed to have an acute effect and is a solution for chronic cough, which is one of the major symptoms experienced by 80%% of IPF patients. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| SENSIDOSE AB | Electronic Equipment/Instruments | Director of Finance/CFO Director/Board Member | |
| BIOEXTRAX AB | Biotechnology | Director of Finance/CFO |
Statistieken
Internationaal
| Zweden | 44 |
| Noorwegen | 3 |
| Australië | 3 |
| Verenigd Koninkrijk | 2 |
| Verenigde Staten | 2 |
Sectoraal
| Health Technology | 18 |
| Consumer Services | 9 |
| Commercial Services | 7 |
| Distribution Services | 2 |
| Electronic Technology | 2 |
Operationeel
| Director/Board Member | 73 |
| Chief Executive Officer | 31 |
| Corporate Officer/Principal | 29 |
| Director of Finance/CFO | 27 |
| Founder | 26 |
Sterkste connecties
- Beurs
- Insiders
- Bert Roland Kari Junno
- Bedrijfsconnecties
